about
Group V phospholipase A(2) increases pulmonary endothelial permeability through direct hydrolysis of the cell membranePhospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic interventionThe evolving proteome of a complex extracellular matrix, the Oikopleura housePhospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizationsPhospholipase A2 biochemistryRelationship between membrane permeability and specificity of human secretory phospholipase A(2) isoforms during cell deathLarge-scale metabolomic profiling identifies novel biomarkers for incident coronary heart diseaseUsing neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease.Secretory phospholipase-A2 and fatty acid composition in oral reactive lesions: a cross-sectional studyAtsPLA2-alpha nuclear relocalization by the Arabidopsis transcription factor AtMYB30 leads to repression of the plant defense response.Bioactive products generated by group V sPLA(2) hydrolysis of LDL activate macrophages to secrete pro-inflammatory cytokines.Secretory phospholipase A2 enzymes as pharmacological targets for treatment of diseaseGroup X secretory phospholipase A2 regulates the expression of steroidogenic acute regulatory protein (StAR) in mouse adrenal glandsSynthesis of oligo(ethylene glycol) substituted phosphatidylcholines: secretory PLA2-targeted precursors of NSAID prodrugsResearch resource: estrogen-driven prolactin-mediated gene-expression networks in hormone-induced prostatic intraepithelial neoplasiaGroup X secretory phospholipase A2 negatively regulates adipogenesis in murine modelsCharacterization of Plp, a phosphatidylcholine-specific phospholipase and hemolysin of Vibrio anguillarumEctopically expressed pro-group X secretory phospholipase A2 is proteolytically activated in mouse adrenal cells by furin-like proprotein convertases: implications for the regulation of adrenal steroidogenesisLysophosphatidylcholine: A Novel Modulator of Trypanosoma cruzi TransmissionLipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertensionPhospholipase A2IVα regulates phagocytosis independent of its enzymatic activityInflammation-associated changes in lipid composition and the organization of the erythrocyte membrane.Group V secretory phospholipase A2 enhances the progression of angiotensin II-induced abdominal aortic aneurysms but confers protection against angiotensin II-induced cardiac fibrosis in apoE-deficient mice.A Non-Targeted Liquid Chromatographic-Mass Spectrometric Metabolomics Approach for Association with Coronary Artery Disease: An Identification of Biomarkers for Depiction of Underlying Biological MechanismsPhospholipase A2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases.Phospholipases in action during plant defense signaling.Emerging anti-inflammatory drugs for atherosclerosis.Acidification of the intimal fluid: the perfect storm for atherogenesisBiochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.Group V phospholipase A2 mediates barrier disruption of human pulmonary endothelial cells caused by LPS in vitroInhibition of Neurotoxic Secretory Phospholipases A(2) Enzymatic, Edematogenic, and Myotoxic Activities by Harpalycin 2, an Isoflavone Isolated from Harpalyce brasiliana Benth.High plasma phospholipase A2 activity, inflammation markers, and LDL alterations in obesity with or without type 2 diabetes.Phospholipase A2 inhibitors in the treatment of atherosclerosis: a new approach moves forward in the clinic.Secreted phospholipase A2 is increased in meconium-stained amniotic fluid of term gestations: potential implications for the genesis of meconium aspiration syndrome.Diverse Functions of Secretory Phospholipases A2
P2860
Q24294374-457E7ECB-D046-438A-8BE9-80744D284161Q26997377-7EA2556C-C2E8-40BD-9376-A01EF9A9FC47Q27335424-0779FC1E-7254-459B-8AEC-B6C9BE155251Q28286551-02C5E73C-8C91-48A5-843C-DCE003691606Q28297979-85969B2D-A994-40E9-A3B1-222B1A70EBBBQ28388757-67A5D989-5863-4AC3-958C-1830FCE62210Q28542665-BCFEF7B0-3277-457B-9B53-116B11578BECQ30451918-CBA9DA32-2EFC-4F8E-8A0C-445B733C2C7EQ33612945-D290F199-EC7A-4C37-9364-40C116E3487CQ33653178-B72D8828-CB59-49CB-8B47-1ECDF5526992Q33771533-FC668322-9036-4DF5-8376-080D494D94F4Q33923169-8E454851-1B73-424E-8979-1CD5A92D8F90Q33924348-817BB7A7-2FD3-4CCE-9795-1B09A3C875B7Q34081569-219A04D5-885B-4D5B-AD5E-68BDBE641EE5Q34220101-BB8055A3-0F90-4430-8B89-7A43614275CCQ34281664-094B9956-BC45-46CC-8CF5-413C348ABAF4Q34463530-1D7FD4D6-A803-4154-B509-7C8481AF0F3DQ35199443-C69F464F-3C1E-4CE6-93B8-8AF6D3DBD7A1Q35503605-8BF3B8C3-6825-4485-B852-7514D8079F68Q35540342-779B61D3-0B13-480A-99F6-B1F1786ECAB1Q35956700-CC4ACC25-3AF2-4F8E-BF9C-A9DC01AFFA2DQ36023408-422EECD0-AD62-426C-8260-548569D17E34Q36204176-C9523D3A-B0D4-419F-BEBE-B2620320B6C4Q37635546-44D9507B-E371-48AB-87D2-E9BD29CD9261Q37658843-C2B381BF-CE29-47F2-A6D8-0C18FF3736F1Q37830258-438D891D-B4FB-420D-836F-837603E3ABC1Q38106998-356CB25E-5DB9-4546-9D80-75DFC72CA5ABQ38271332-B1E2D375-2CD7-41A7-9F2F-E6BE0024AF04Q38957246-1B0B48E6-1ADC-4D24-9BFF-4B3BD078296FQ41913390-F06DCD70-AD70-46BE-8DDE-3F69ABAE68F2Q42140983-EF739305-6108-4D6A-B1C1-7D525068D2C6Q43172296-42D93CC2-0B56-49F4-94D2-187DF84B683AQ43289695-2461D0E4-2C6A-4CAE-9171-ADC1B36FB327Q43981244-27DEDCE9-5880-4A81-AED9-39A07C6A831FQ59050854-3F2FBEBC-D547-4462-8C9C-1AB014BBAAD7
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biology of secretory phospholipase A2.
@en
Biology of secretory phospholipase A2.
@nl
type
label
Biology of secretory phospholipase A2.
@en
Biology of secretory phospholipase A2.
@nl
prefLabel
Biology of secretory phospholipase A2.
@en
Biology of secretory phospholipase A2.
@nl
P2860
P1476
Biology of secretory phospholipase A2.
@en
P2093
Boris B Boyanovsky
Nancy R Webb
P2860
P356
10.1007/S10557-008-6134-7
P577
2008-10-14T00:00:00Z